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Abstract
Background: While better outcomes at high‐volume surgical centers have driven
regionalization of complex surgical care, access to high‐volume centers often requires
travel over longer distances. We sought to evaluate travel patterns of patients
undergoing pancreaticoduodenectomy (PD) for pancreatic cancer to assess
willingness of patients to travel for surgical care.
Methods: The California Office of Statewide Health Planning database was used to
identify patients who underwent PD between 2005 and 2016. Total distance
traveled, as well as whether a patient bypassed the nearest hospital that performed
PD to get to a higher‐volume center was assessed. Multivariate analyses were used to
identify factors associated with bypassing a local hospital for a higher‐volume center.
Results: Among 23 014 patients who underwent PD, individuals traveled a median
distance of 18.0 miles to get to a hospital that performed PD. The overwhelming majority
(84%) of patients bypassed the nearest providing hospital and traveled a median
additional 16.6 miles to their destination hospital. Among patients who bypassed the
nearest hospital, 13,269 (68.6%) did so for a high‐volume destination hospital.
Specifically, average annual PD volume at the nearest “bypassed” vs final destination
hospital was 29.6 vs 56 cases, respectively. Outcomes at bypassed vs destination
hospitals varied (incidence of complications: 39.2% vs 32.4%; failure‐to‐rescue: 14.5% vs
9.1%). PD at a high‐volume center was associated with lower mortality (OR= 0.46 95%
CI, 0.22‐0.95). High‐volume PD ( > 20 cases) was predictive of hospital bypass (OR= 3.8
95% CI, 3.3‐4.4). Among patients who had surgery at a low‐volume center, nearly 20%
bypassed a high‐volume hospital in route. Furthermore, among patients who did not
bypass a high‐volume hospital, one‐third would have needed to travel only an additional
30 miles or less to reach the nearest high‐volume hospital.
Conclusion:Most patients undergoing PD bypassed the nearest providing hospital to seek
care at a higher‐volume hospital. While these data reflect increased regionalization of
complex surgical care, nearly 1 in 5 patients still underwent PD at a low‐volume center.
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1 | INTRODUCTION
Americans face an increasing and diverse number of barriers to
access healthcare. Potential barriers include insurance status, health
literacy, and cost, all of which have been extensively examined.1-3
Another less studied barrier is the distance needed to travel to
obtain care.4,5 Specifically, with increased emphasis on centralization
of healthcare networks and particularly surgical services, rural
hospitals are at an increased risk of foreclosure.6-10 While the
number of major surgical hospitals increased over the decade from
2005 to 2015, there was an 82% increase in the number of people
who lived further than an hour from any hospital, let alone a high‐
volume surgical center.4 In fact, up to 10% of the United States
population resides outside a 30 mile radius of a hospital with the
capacity to perform adult inpatient surgery.5 While access to surgical
services has been examined through the lens of insurance, race, and
health literacy, the relationship of travel distance to access, in the
context of surgical cancer care, has only more recently become an
area of closer focus.11,12
Surgical services are a large part of curative‐intent therapy for
patients with cancer. High‐volume surgical centers have lower
morbidity and mortality compared with low‐volume centers, espe-
cially among patients undergoing more complex and high‐risk cancer‐
related surgical procedures.13-15 These high‐volume centers are
often located, however, in urban areas, which compounded by the
closure of existing rural hospital‐based surgical services, may hinder
rural community access to high‐quality surgical care.13,15-17 For
example, although the number of hospitals that provided surgical
services with an approved American College of Surgeons (ACS)
cancer program slightly increased since 2005, the number of people
living greater than 60minutes has increased from 6% to 11%.18
The call to centralize complex surgical procedures, including
operations associated with cancer treatment, to high‐volume centers
has the potential to create a significant barrier of increased travel
burden on potentially vulnerable populations.16,19 Understanding the
characteristics of patients and travel burden experienced by
individuals who must travel to receive surgical cancer care is,
therefore, important. The objective of the current study was to
characterize travel patterns among patients who underwent pan-
creaticoduodenectomy (PD) for cancer. In particular, we sought to
determine the travel distance burden among patients undergoing PD,
as well as examine whether patients were likely to bypass a closer
hospital that performed PD to access a different center.
2 | METHODS
2.1 | Data and study population
A cohort analysis of the California Office of State‐wide Health
Planning and Development20 (OSHPD) hospital discharge database
from 2005 to 2016 was performed. As a department within the
California Health and Human Services Agency, the OSHPD oversees
the collection and dissemination of healthcare information from
licensed practitioners and hospitals within California, resulting in
complete capture of all hospital stays for California patients. The
data were appropriately deidentified with encrypted ID assignments.
The International Classification of Diseases, ninth and tenth
Revision (ICD‐9 and ICD10) diagnosis and procedure codes were
utilized to define the population of interest. Specifically, patients with
a diagnosis of pancreatic, duodenal, or biliary neoplasm (See
Appendix 1 for ICD codes) who underwent a PD (See Appendix 1
for ICD codes) were included in the analytic cohort (n = 23 014).
Patient‐specific variables selected for analysis included age, race/
ethinicity, sex, and insurance type. Hospital variables included
teaching hospital status, number of beds, number of operating
rooms, and annual PD hospital volume and in‐hospital all‐cause
mortality for PD. Outcomes of interest were total real driving
distance traveled to reach destination hospitals, as well as the
incidence of patients who bypassed a hospital that performed PD to
reach a different center that performed PD surgery.
2.2 | Geospatial analysis
Data were imported into QGIS 2.18 statistical package for geospatial
analysis (QGIS Development Team, 2009. QGIS Geographic
TABLE 1 Patient and hospital level characteristics for patients
undergoing pancreaticoduodenectomy, 2005‐2016
Patient characteristics (N = 23 014)
Median distance traveled (Miles) (IQR) 18.0 7.6‐42.0
Bypassed nearest providing hospital (%) 19 327 83.9%
Age (Mean) [SD] 65.54 11.37
Sex
Male 12 026 52.3%
Female 10 988 47.7%
Race (%)
White 14 505 63.0%





Self pay 289 1.3%
Medicaid 1796 7.8%
Medicare 11 902 51.7%
Private 8536 37.1%
Other 289 1.3%
Destination hospital characteristics (n = 189)
Annual procedure volume (mean SD) 10.17 20.7
High volume ( > 20 PD per y) 14 510 63.05
In‐hospital mortality rate (mean SD) 3.7 0.19
LOS (days) (mean SD) 15.16 12.08
Charge $USD (mean SD) 220 496 265 755
Total admissions (mean SD) 21 335.87 9398.36
Total beds (mean SD) 432.58 191.87
Total operating rooms (mean SD) 25.58 11.47
Academic Medical Center (Total, %) 17 803 77.36
Full time nurses (mean SD) 1404.1 674.37
Abbreviations: LOS, length‐of‐stay; PD, pancreaticoduodenectomy.
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Information System. Open Source Geospatial Foundation). Hospitals
were geocoded using the reported address. Using OpenStreetMaps
road and traffic data and osm2po routing engine, travel distances were
calculated to each hospital.21 The nearest hospital assigned to each
patient was determined by the shortest driving distance between the
patient’s corresponding residential zip code and a given hospital
location. Patients were defined as bypassing the nearest providing
facility if the actual travel distance surpassed the shortest calculated
travel distance. Differential distance was then calculated as the
difference in distance between the destination and nearest hospitals.
2.3 | Statistical methods
Unadjusted analyses were performed for comparison of patients who
did and did not bypass a hospital for PD using χ2and t test for
categorical and continuous variables, respectively. Multivariate analy-
sis was utilized to identify factors associated with bypassing a hospital
while controlling for patient demographics, hospital teaching status,
PD volume, as well as mortality of the destination hospital. All
statistical analyses were performed using Stata statistical software
version 16 (College Station, TX). All tests were two‐sided, and P values
of less than .05 were considered to indicate statistical significance.
3 | RESULTS
Among the 23 014 patients who underwent PD for a neoplasm of
the pancreas, duodenum, or bile duct in California between 2005
and 2016, mean patient age was 65 years and roughly one‐half
(52.3%) of patients were male. The majority of patients were White
(63%), followed by Hispanic (16.2%), Asian (11.4%), and African
American (5.6%). Half the cohort was insured by Medicare (51.7%),
whereas other patients had private insurance (37.1%), Medicaid
(7.8%), or were self‐pay (1.3%). Among the 189 hospitals that
performed PD, overall mean annual PD volume was 10; 23 hospitals
were identified as high‐volume centers, defined using the Leap Frog
criteria as an average annual PD volume > 20 (Table 1).22 Roughly
two‐thirds of patients (n = 14 510, 63.1%) underwent PD at a high‐
volume center. Following PD, overall mean length‐of‐stay (LOS) was
15.2 days (IQR 8.0‐17.0) (low‐volume centers: mean LOS, 17.0 days
vs high‐volume center: mean LOS, 14.1 days) with a 30‐day
mortality of 3.7% (low‐volume centers: in hospital mortality, 5.9%
vs high‐volume centers: in hospital mortality, 2.4%) (both P < .05).
Mean number of hospital beds was 432.6 (low‐volume: 295.9 vs
high‐volume: 500.8), mean number of operating rooms 25.6 (low‐
volume: 16.2 vs high‐volume: 29.1), and most hospitals (77.4%)
TABLE 2 Unadjusted comparison of patient and hospital characteristics based on hospital bypass status
Nearest hospital (n = 3687) Bypassed hospital (n = 19 327) P
Median miles traveled (IQR) 4.72 2.91‐11.44 21.34 10.04‐49.18 < .001
Age 67.07 66.71‐67.43 65.25 65.09‐65.41 < .001
Race
White 2412 65.4% 12 093 62.6% < .001
Black 235 6.3% 1059 5.5%
Hispanic 575 15.6% 3163 16.3%
Asian 337 9.1% 2295 11.9%
Other 128 4.4% 717 3.7%
Sex
Male 4380 51.4% 7665 52.7% < .001
Female 4136 48.6% 6877 47.3%
Insurance
Self pay 43 1.2% 246 1.3% < .001
Medicaid 281 7.6% 1515 7.9%
Medicare 2136 57.9% 9766 51.0%
Private 1176 31.9% 7360 38.5%
Other 51 1.4% 246 1.3%
Destination hospital characteristics
Annual procedure volume (mean SD) 29.57 28.29‐30.84 55.99 55.35‐56.62 < .001
High volume ( > 20 PD per y) 33.7% 32.13‐35.18 68.6% 68.0‐69.31
In‐hospital mortality rate (mean SD) 6.08% 5.30‐6.84 3.21% 2.96‐3.46 < .001
LOS (days) 17.1 16.65‐17.46 14.8 14.63‐14.97 < .001
Charge ($USD) 229 951.70 221 595‐238 308 218 692 214 927‐222 457 .0184
Complication 39.2% 37.59‐40.74 32.4% 31.69‐33.01 < .001
Failure to rescue 14.47% 12.66‐16.29 9.1% 8.43‐9.86 < .001
Academic medical center 60.4% 58.77‐61.93 80.6% 80.04‐81.16 < 0.001
Total admissions 18 956 18 628‐19 284 21 774 21 640‐21 908 < .001
Total beds 371.52 365.01‐378.04 443.83 441.09‐446.57 < .001
Total operating rooms 20.9 20.48‐21.37 26.4 26.20‐26.55 < .001
Full time RN 1120.1 1091.16 − 1148.98 1449.6 1439.03‐1460.13 < .001
Abbreviations: LOS, length‐of‐stay; PD, pancreaticoduodenectomy.
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were academic medical centers (low‐volume: 52.5% vs high‐volume:
91.9%) (all P < .05).
Comparing travel patterns among patients undergoing PD, 3687
(16.0%) patients underwent surgery at the nearest hospital available
whereas 19 327 (84.0%) patients bypassed the nearest hospital to
travel to a different center (Table 2). On average, patients traveled
18.0 (IQR: 7.64‐42.00) miles to the hospital at which PD was
performed (final destination low‐volume hospital: 10.8 miles vs final
destination high‐volume hospital: 23.5 miles) (Table 1). Specifically,
among patients who bypassed a closer hospital, 13 269 (68.6%)
individuals underwent PD at a high‐volume center vs 6058 (31.34%)
patients who had a PD at a low‐volume center (P < .05). Patients who
underwent PD at the nearest hospital had a median travel distance of
4.7 miles vs a travel distance of 21.3 miles among patients who
bypassed the closest hospital to undergo PD at a more distant center
(P < .05). Of note, the annual PD volume at closer hospitals vs
destination hospitals was considerably lower (29.6 vs 56.0, respec-
tively) (P < .05). The odds of undergoing PD at a high‐volume hospital
was higher among patients who had bypassed the nearest hospital
(OR, 3.82, 95% CI, 3.31–4.41) (Table 3).
Compared with the nearest hospital, destination PD hospitals
were likely to be academic medical centers (nearest: 60.4% vs
destination: 80.6%), had more mean annual admissions (nearest:
21,774 vs destination: 18 956), more hospital beds (nearest: 372 vs
destination: 444), more operating rooms (nearest: 21 vs destination:
26.4), as well as more full time nurses (nearest: 1120 vs destination:
1450) (all P < .05) (Table 2). In turn, peri‐operative morbidity
(nearest: 32.4% vs destination: 39.2%), failure‐to‐rescue (nearest:
14.5% vs destination: 9.1%), as well as mortality (nearest: 6.1% vs
destination: 3.2%) were all lower among patients who had bypassed a
closer hospital to travel to a further destination hospital that
performed PD (all P < .05). Of note, among a subset analysis of 8503
patients who underwent PD at a low‐volume hospital, 1459 (17.2%)
patients had actually bypassed a high‐volume hospital to have
surgery at a low‐volume center. In this subset of patient, there was
no difference in the distance traveled among Medicare beneficiaries
and privately insured patients (54.7 vs 50.4 miles); Medicaid
beneficiaries (33.6 miles, P < .001) traveled shorter distances. Among
the 7044 individuals who did not bypass a high‐volume hospital,
roughly one‐third (n = 2379, 33.8%) would have needed to travel an
additional 30 miles or less to reach the nearest high‐volume hospital;
922 (13.1%) patients would have needed to travel an additional 100
miles or greater to reach the nearest high‐volume hospital (Table 4).
On multivariable analysis, African American (OR, 1.28, 95% CI,
1.02‐1.60), Hispanic (OR, 1.53 95% CI, 1.31‐1.79), and Asian (OR,
1.86, 95% CI, 1.57‐2.21) patients were more likely to have bypassed
the nearest hospital to go to a different center. Among African
American, Hispanic, and Asian patients who did bypass a closer
hospital, more than half (59.8.%, 61.2%, and 68.4%) bypassed a low‐
volume center to go to high‐volume center for PD. However, roughly
1 in 3 African American (40.2%), Hispanic (38.8%), and Asian (31.8%)
patients bypassed a closer hospital to undergo PD simply at a
different low‐volume hospital. Of note, age, sex, or insurance type
were not associated with odds of a patient bypassing the nearest
hospital (all P > .05).
4 | DISCUSSION
Access to high‐quality inpatient oncologic surgical services is a major
population health priority. Access to care may be limited by a number
of factors including, but not limited to, insurance status, ability to pay,
availability of hospital/provider, and ability to take time off from
work. While travel time and distance may also impact access to
subspecialty, complex surgical services, this topic has not been well‐
studied. The current study was important because we specifically
examined both travel distance, as well as the incidence of bypassing
closer hospitals, to receive PD surgery. In particular, unlike previous
studies, true travel distance was assessed using geocoding software
and traffic data. Of note, among the over 23 000 patients who
underwent PD in California between 2005 and 2016, 84% bypassed
the closest hospital to their home to travel a median distance of 18
miles for surgery (Figure 1). While the odds of undergoing PD at a
high‐volume hospital was higher among patients who had bypassed
the nearest hospital, a significant number of patients who bypassed a
closer hospital still underwent PD at a low‐volume hospital. In fact,
TABLE 3 Multivariable analysis of patient and hospital
characteristics as predictors for bypassing nearest providing hospital
OR 95% CI P
Total distance traveled 3.46 3.27‐3.67 < .001
Age 0.99 0.98‐0.99 < .001
Race/Ethnicity
White Ref
African American 1.28 1.02‐1.60 < .001
Hispanic 1.53 1.31‐1.79 < .001
Asian 1.86 1.57‐2.21 < .001
Sex
Male Ref
Female 0.94 0.85‐1.05 .262
Insurance
Medicare Ref
Medicaid 1.15 0.91‐1.44 .236
Private 0.99 0.86‐1.16 .989
Self pay 1.26 0.82‐1.95 .293
Other 1.29 0.85‐1.94 .234
In‐hospital mortality 1.06 0.83‐1.37 .626
Complications 0.98 0.87‐1.10 .756
High volume ( > 20 cases) 3.82 3.31‐4.41 < .001
Charge 1.00 0.99‐1.00 .485
Academic medical center 1.13 0.99‐1.30 .077
Total admission 1.00 0.99‐0.99 < .001
Total beds 1.00 1.00‐1.00 < .001
Total operating rooms 1.00 0.99‐1.01 .674
Full time RN 1.00 0.99‐0.99 < .001
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nearly 20% of patients actually bypassed a high‐volume hospital in
route to have surgery at a low‐volume center. Furthermore, among
patients who did not bypass a high‐volume hospital, one‐third would
have needed to travel only an additional 30 miles or less to reach the
nearest high‐volume hospital (Figure 2).
Data from the current study demonstrated that patients were
indeed willing to travel longer distances and bypass closer hospitals
to receive certain types of complex medical care such as PD.
Interestingly, these data differed from other studies that had
suggested that patients preferred to seek medical care closer to
their home.23,24 The reason for these disparate results was
undoubtedly multifactorial and may have been related to differences
in surgical procedures being considered. For example, patients may
prefer to seek medical care, as well as be referred to local surgeons,
for certain operations generally considered lower risk (eg, distal
gastrectomy and colectomy).23,24 In contrast, complex surgical
procedures such as PD that involve more potential morbidity and
mortality may often cause local physicians to refer patients to
regional high‐volume centers.25 In addition, patients may self‐select
more experienced centers when faced with a disease that requires
more specialized surgical care.26 While local referrals to low‐cost
hospitals for some procedures may be associated with acceptable
morbidity and mortality, referral to high‐volume centers may provide
more value for other types of complex operations.25,27,28 Regiona-
lization of care can, however, force patients to travel longer
distances. To this point, patients who underwent PD at the nearest
hospital had a median travel distance of 4.7 miles vs a travel distance
of 21.3 miles among patients who bypassed the closest hospital to
undergo PD at a more distant center. Perhaps of even more interest
was the finding that a large subset of patients actually traveled past a
closer high‐volume hospital ultimately to undergo PD at a low‐
volume center. Specifically, this phenomenon was most pronounced
among underrepresented minority patients as roughly 1 in 3 African
American, Hispanic, and Asian patients bypassed a closer hospital to
undergo PD simply at a different low‐volume hospital. Of note, other
investigators have similarly noted that some patients may have a
tendency to travel beyond high‐volume centers in favor of seeking
surgery at low‐volume hospitals, despite a higher chance of surgery‐
related mortality at these centers.19,29 Patients willingness to travel
for higher level of care can improve both short‐ and long‐term
outcomes, especially for patients with complex diseases such as liver
and pancreatic cancer.30-32 The decision to where to have ones
complex oncologic operation is certainly a complex one. While we
have shown that patients are willing to travel longer distances for
their PD operation, there are several unmeasured variables that may
also be influencing a patients decision to travel further. For example,
a patients’ relationships with previous providers matter a great deal
and therefore referral patterns would certainly have a major
influence as to where patients may ultimately choose to have their
operation. In addition, a patients insurance and more importantly
whether a hospital or provider is covered by the patients insurance
provider will more likely than not play a large role in the patients
decision to where to have surgery. Hospital systems, and insurance
networks are in the unique position to centralize care so that their
patients can receive their operation at the hospital that offers the
greatest chance at a good outcome with the highest value.
TABLE 4 Patient characteristics for patients undergoing pancreaticoduodenectomy at low‐volume hospitals
Patient characteristics (N = 8503)
Bypassed high‐volume hospital (%) 1459 17.2
Median Miles traveled (IQR) 6.89 2.50‐13.35
Did not bypass high‐volume hospital (%) 7044 82.8
Median additional miles HVH (IQR) 56.76 15.78‐82.38
Range of additional miles traveled < 30 30‐100 > 100 Total
Total (%) 2379 (33.8) 3743 (53.1) 922 (13.1) 7044
Age (mean) [SD] 66.00 (10.9) 65.82 (11.07) 66.05 (11.11)
Sex
Male 1225 (33.7) 1958 (53.9) 451 (12.4) 3634
Female 1154 (33.8) 1785 (52.35) 471 (13.8) 3410
Race
White 1308 (30.3) 2352 (54.4) 664 (15.4) 4324
African American 162 (33.7) 275 (57.2) 44 (9.2) 481
Hispanic 588 (44.5) 595 (45.0) 138 (10.5) 1321
Asian 256 (35.3) 407 (56.1) 62 (8.6) 725
Other 65 (33.7) 114 (59.1) 14 (7.3) 193
Insurance
Self pay 25 (28.4) 55 (62.5) 8 (9.1) 88
Medicaid 245 (37.9) 332 (51.4) 69 (10.7) 646
Medicare 1218 (32.6) 2020 (54.0) 501 (13.4) 3739
Private 860 (35.6) 1229 (50.8) 329 (13.6) 2418
Other 31 (20.3) 107 (69.9) 15 (9.8) 153
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The volume‐outcome relationship related to complex surgical
procedures has been well‐documented.13-15 In the current centers, it
was interesting to note that destination PD hospitals were likely to
be academic medical centers, had more mean annual admissions,
more hospital beds, more operating rooms, as well as more full time
nurses (Table 2). In aggregate, patients who bypassed a closer
hospital to be treated at a destination had lower peri‐operative
morbidity and failure‐to‐rescue, as well as an incidence of peri‐
operative mortality that was almost one‐half lower. Previous work
from our group and others have demonstrated that high‐volume
centers, especially centers with a teaching designation, have
improved outcomes associated with high‐risk surgical procedures.33
For example, Hyder et al34 noted that quality metrics such as length‐
of‐stay and mortality following complex hepatopancreaticobiliary
surgery were also better at high‐volume academic medical centers.
Our group has previously characterized the association between
travel distance and hospital volume relative to outcomes following
resection of cholangiocarcinoma, gallbladder cancer, and hepatocel-
lular carcinoma.35-38 Both increasing travel distance and hospital
volume were associated with improved overall survival; however,
adjusted models demonstrated that the impact of travel distance was
largely mediated through hospital volume. Collectively, the data
strongly suggest that bypassing a closer hospital to travel to a
destination hospital that is higher volume should generally be
encouraged for patients seeking PD as surgical treatment.
While longer travel distances may translate into more patients
receiving surgical care at high‐volume regional centers, other aspects of
the multimodality care of the cancer patient also need to be considered.
For example, Idrees et al39 reported that centralization of surgery for
cholangiocarcinoma to high‐volume hospitals increased compliance with
National Comprehensive Cancer Network guidelines. Other studies,
however, have suggested that longer travel distances can impede a
patients ability to receive other nonsurgical therapies. For example,
patients with prostate cancer in both urban and rural settings were less
likely to receive radiation therapy rather than surgery the farther away
they lived from a treatment center. These findings raise the possibility
that the geographic availability of radiation treatment centers may be an
important determinant of whether patients are able to choose radiation
rather than surgery for localized prostate cancer.40 In a different study,
Lin et al41 reported that increased travel burden was associated with a
decreased likelihood of receiving adjuvant chemotherapy. In addition,
increased travel burden may also be associated with decreased likelihood
of receiving adjuvant radiation therapy for a variety of cancers.42 Of note,
the travel distance burden may affect vulnerable populations dispropor-
tionately. For example, among patients undergoing pancreatectomy, the
elderly, racial minorities, and patients with self‐pay or Medicaid payer
status were most sensitive to travel burden.14 Access to comprehensive
oncologic care at major cancer programs is important because delays in
treatment may lead to worse oncologic outcomes.43-45
Several limitations should be considered when interpreting the
results. While the California database allowed for 100% capture with
F IGURE 1 Total patient travel distance to reach destination
hospitals to undergo PD by California County
F IGURE 2 Total distance to nearest
high‐volume center for patients who
underwent surgery at a low‐volume center
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complete evaluation of travel for all patients receiving surgery at
California‐licensed facilities, the data were limited to one state and
therefore the data may not be generalizable to other geographically
distinct states. While possible reasons for traveling could include
personal preferences, level of education, financial constraints for
both medical and nonmedical expenses, or referral practices of
diagnosing providers, we were not able to define specific reasons
why patients did or did not bypass a hospital or travel further
distances. For example, an important missing variable is patient
income, which would likely affect a patient’s ability and tolerance for
increased travel. Volume and mortality data were also analyzed at
the hospital level, thus making it difficult to understand how patient
travel decisions were influenced by individual surgeon outcomes.
Finally, the California state database lacked certain cancer‐specific
information and therefore we were not able to examine if and where
patients received chemotherapy or other cancer‐specific treatments.
In conclusion, most patients undergoing PD bypassed the nearest
providing hospital to seek care at a higher‐volume hospital. While the
data demonstrated increased regionalization of complex surgical
care, nearly 1 in 5 patients still underwent PD at a low‐volume
center. Importantly, nearly half of patients who had PD at a low‐
volume center could have undergone surgery at a high‐volume center
with minimal increase in travel burden. These data would support the
facilitation of patient travel to destination high‐volume centers for
patients in need of PD. Such data support employer‐based plans that
offer employees the opportunity to receive care at regional centers
of excellence with no additional personal travel cost.46,47
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APPENDIX: ICD 9 and ICD 10 diagnosis and
procedure codes
Pancreatic resection for cancer
• Diagnosis codes
a. ICD9
▪ 152 ‐ Malignant neoplasm of small intestine including duodenum.
▪ 156 ‐Malignant neoplasm of gallbladder and extrahepatic bile
ducts.
▪ 157 ‐ Malignant neoplasm of pancreas.
b. ICD10
▪ C23 Malignant neoplasm of gallbladder.
▪ C240 Malignant neoplasm of extrahepatic bile duct.
▪ C241 Malignant neoplasm of ampulla of Vater.
▪ C248 Malignant neoplasm of overlapping sites of biliary tract.
▪ C249 Malignant neoplasm of biliary tract, unspecified.
▪ C250 Malignant neoplasm of head of pancreas.
▪ C251 Malignant neoplasm of body of pancreas.
▪ C252 Malignant neoplasm of tail of pancreas.
▪ C253 Malignant neoplasm of pancreatic duct.
▪ C254 Malignant neoplasm of endocrine pancreas.
▪ C257 Malignant neoplasm of other parts of pancreas.
▪ C258 Malignant neoplasm of overlapping sites of pancreas.
▪ C259 Malignant neoplasm of pancreas, unspecified.
▪ C170 Malignant neoplasm of duodenum.
• Procedure codes
a. ICD9
▪ 5252 ‐ distal pancreatectomy.
▪ 5259 ‐ other partial pancreatectomy.
▪ 5251 ‐ proximal pancreatectomy.
▪ 5253 ‐ radical subtotal pancreatectomy/whipple.
▪ 527 ‐ radical pancreatoduodenectomy.
▪ 526 ‐ total pancreatectomy.
b. ICD10
▪ 0FTG0ZZ ‐ Resection of Pancreas, Open Approach.
▪ 0FTG4ZZ ‐ Resection of Pancreas, Percutaneous Endoscopic
Approach.
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